Toll-like receptor 2 does not contribute to host response during postinfluenza pneumococcal pneumonia.
暂无分享,去创建一个
[1] S. Akira,et al. Toll‐like receptor 9 acts at an early stage in host defence against pneumococcal infection , 2007, Cellular microbiology.
[2] Lena Alexopoulou,et al. Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus–Induced Acute Pneumonia , 2006, PLoS pathogens.
[3] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[4] T. Mitchell,et al. Innate immunity and the pneumococcus. , 2006, Microbiology.
[5] K. Hartshorn,et al. Influenza A Viruses Upregulate Neutrophil Toll‐Like Receptor 2 Expression and Function , 2006, Scandinavian journal of immunology.
[6] Shizuo Akira,et al. Innate immune recognition of viral infection , 2006, Nature Immunology.
[7] T. van der Poll,et al. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. , 2006, The Journal of infectious diseases.
[8] T. van der Poll,et al. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[9] M. Hornef,et al. Myeloid differentiation factor 88‐dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice , 2005, Cellular microbiology.
[10] S. Akira,et al. The MyD88-Dependent, but Not the MyD88-Independent, Pathway of TLR4 Signaling Is Important in Clearing Nontypeable Haemophilus influenzae from the Mouse Lung1 , 2005, The Journal of Immunology.
[11] M. Levin,et al. Varicella-Zoster Virus Activates Inflammatory Cytokines in Human Monocytes and Macrophages via Toll-Like Receptor 2 , 2005, Journal of Virology.
[12] Rajagopal N. Aravalli,et al. Cutting Edge: TLR2-Mediated Proinflammatory Cytokine and Chemokine Production by Microglial Cells in Response to Herpes Simplex Virus1 , 2005, The Journal of Immunology.
[13] M. Netea,et al. From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias , 2005, Antimicrobial Agents and Chemotherapy.
[14] J. P. Long,et al. Alteration of gene expression in human middle ear epithelial cells induced by influenza A virus and its implication for the pathogenesis of otitis media. , 2004, Microbial pathogenesis.
[15] N. Reiling,et al. CD14 is required for influenza A virus-induced cytokine and chemokine production. , 2004, Immunobiology.
[16] T. van der Poll,et al. IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection , 2004, The Journal of Immunology.
[17] S. Akira,et al. Toll-Like Receptor 2 Plays a Role in the Early Inflammatory Response to Murine Pneumococcal Pneumonia but Does Not Contribute to Antibacterial Defense1 , 2004, The Journal of Immunology.
[18] R. Bronson,et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] T. van der Poll,et al. Role ofToll-Like Receptor 4 in Gram-Positive and Gram-Negative Pneumonia inMice , 2004, Infection and Immunity.
[20] D. Golenbock,et al. Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2 , 2003, Journal of Virology.
[21] M. Lipsitch,et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] T. van der Poll,et al. Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. , 2003, American journal of respiratory and critical care medicine.
[23] H. Wagner,et al. Toll-Like Receptor 2 Participates in Mediation of Immune Response in Experimental Pneumococcal Meningitis1 , 2003, The Journal of Immunology.
[24] K. Frei,et al. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. , 2002, The Journal of infectious diseases.
[25] T. van der Poll,et al. TNF-α Compensates for the Impaired Host Defense of IL-1 Type I Receptor-Deficient Mice During Pneumococcal Pneumonia1 , 2001, The Journal of Immunology.
[26] I. Julkunen,et al. IFNs activate toll-like receptor gene expression in viral infections , 2001, Genes and Immunity.
[27] P. Schipper,et al. Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR , 2001, Journal of Clinical Microbiology.
[28] S. Akira,et al. Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection1 , 2000, The Journal of Immunology.
[29] Michael J Fine,et al. Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] K. O'Brien,et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] S. Akira,et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.
[32] D. Golenbock,et al. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.
[33] L. Simonsen,et al. The impact of influenza epidemics on mortality: introducing a severity index. , 1997, American journal of public health.
[34] L. Leon,et al. Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. , 1997, The American journal of physiology.
[35] T. van der Poll,et al. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. , 1997, American journal of respiratory and critical care medicine.
[36] T. van der Poll,et al. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. , 1996, The Journal of infectious diseases.
[37] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[38] J. Enders,et al. Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.